Back to results
US 11,766,419 B2Granted
Mebeverine as soluble epoxide hydrolase inhibitor
AssigneeBanasthali Vidyapith
InventorsSarvesh Paliwal, Swapnil Sharma, Neetika Tripathi, Kanika Verma, Swati Paliwal
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of using Mebeverine as an sEH inhibitor. The present invention also provides a method of treating metabolic and cardiovascular disorders using Mebeverine.
Claims9
A method for treating a sEH inhibition mediated condition in a subject, comprising:
- administering to the subject a therapeutically effective amount of Mebeverine or a salt thereof,
- wherein the sEH inhibition mediated condition the subject is suffering from is hyperlipidemia.
Dependencies are inferred from the claim text.